Medical Advisory Board
Our Medical Advisory Board is a leading body of scleroderma experts working to improve patient care and scleroderma awareness across the nation. The medical advisory board helps to:
-
Give advice to improve standards of care for scleroderma patients.
-
Create educational forums and literature for patients, families, and healthcare provides to improve patient care
-
Support scleroderma research
-
Encourage collaboration between national and international medical institutions
-
Give general advice on medical standards, credibility, accessibility, advocacy, and communication to medical organizations, such as the National Institute of Health.
Francesco Boin, MD
Cedars-Sinai Medical Center
Los Angeles, CA
David Fiorentino, MD, PhD
Stanford Medicine
Redwood City, CA
Dan E. Furst, MD
UCLA Medical Suites Rheumatology
Los Angeles, CA
JoAnna Harper, PharmD, RPh
Pain Partners LLC
Boise, ID
Suzanne Kafaja, MD
UCLA Health
Los Angeles, CA
Dinesh Khanna, MD, MSc
University of Michigan Medical School
Ann Arbor, MI
David Leader, DMD, MPH
Tufts University School of Dental Medicine
Medford, MA
Michael Macklin, MD
University of Chicago Medicine
Chicago, IL
Marco Matucci-Cerinic, MD, PhD
University of Florence
Florence, Italy and Basel, Switzerland
Carrie Richardson, MD
Northwestern Medicine
Co-Director, Scleroderma Program
Chicago, IL
Lesley A. Saketkoo, MD
Tulane Medical Center
New Orleans, LA
Phillip Clements, MD, MPH
UCLA Health
Los Angeles, CA